Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Honghua Ruyi Wan for chronic pelvic pain due to sequelae of pelvic inflammatory disease
ChiCTR-IPR-15006945Phase 4Not yet recruiting
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Oct 2014
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Honghua Ruyi Pills in Pelviabdominal infection and chronic prostatitis (CP) (2 arms), sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Pain relief after treatment. Planned start Oct 2014; status: not yet recruiting.
02
Drugs
Honghua Ruyi Pills
03
Conditions
Pelviabdominal infectionchronic prostatitis (CP)
Beyond the preview
Go deeper on ChiCTR-IPR-15006945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006945.